» Articles » PMID: 28682917

Link Between Risk of Colorectal Cancer and Serum Vitamin E Levels: A Meta-analysis of Case-control Studies

Overview
Specialty General Medicine
Date 2017 Jul 7
PMID 28682917
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The effect of low serum vitamin E levels on the risk of colorectal cancer (CRC) remains inconclusive. This meta-analysis aims to synthesize relevant studies to evaluate the association between serum vitamin E and the risk of CRC based on case-control studies.

Methods: Potentially relevant studies were selected by searching PubMed, EMBASE, and China National Knowledge Infrastructure databases according to inclusion and exclusion criteria. The association between serum vitamin E levels and CRC was estimated by the weighted mean difference (WMD) and 95% confidence interval (CI) using a random-effects model. Heterogeneity was evaluated using Q test and I statistic. Subgroup analysis was conducted to explore sources of heterogeneity. Sensitivity analysis was performed to reveal stability and reliability.

Results: A total of 10 papers with 11 studies, including 6431 subjects with 520 CRC patients and 5981 controls, were included in this present meta-analysis. The results indicated that compared with healthy controls, patients with CRC showed lower concentrations of serum vitamin E (WMD = -2.994 μmol/L, 95% CI = -4.395 to -1.593). Ethnicity subgroup analysis indicated that the serum vitamin E levels were lower in European (WMD = -1.82 μmol/L, 95% CI = -3.00 to -0.65), but not in Asian. Control-source subgroup analysis revealed that a significant association was observed in subgroup with hospital-based controls (WMD = -3.43 μmol/L, 95% CI = -6.27 to -0.59), but not in those with population-based controls. Sensitivity analysis suggested no significant difference in the pooled estimates, indicating stable results.

Conclusions: CRC is associated with a lower concentration of serum vitamin E. However, necessary prospective cohort studies should be conducted to assess the effect of serum vitamin E on the risk of CRC in the future.

Citing Articles

Role of dietary nutrients and metabolism in colorectal cancer.

Ye J, Bao X, Wei J, Zhang Y, Liu Y, Xin L Asia Pac J Clin Nutr. 2024; 33(2):153-161.

PMID: 38794975 PMC: 11170022. DOI: 10.6133/apjcn.202406_33(2).0002.


Vitamin E and Multiple Health Outcomes: An Umbrella Review of Meta-Analyses.

Xiong Z, Liu L, Jian Z, Ma Y, Li H, Jin X Nutrients. 2023; 15(15).

PMID: 37571239 PMC: 10421296. DOI: 10.3390/nu15153301.


Metabolomic Analysis of Vitamin E Supplement Use in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Lim J, Hong H, Weinstein S, Playdon M, Cross A, Stolzenberg-Solomon R Nutrients. 2023; 15(13).

PMID: 37447163 PMC: 10343751. DOI: 10.3390/nu15132836.


Evaluating Risk: Benefit Ratio of Fat-Soluble Vitamin Supplementation to SARS-CoV-2-Infected Autoimmune and Cancer Patients: Do Vitamin-Drug Interactions Exist?.

Mekky R, Elemam N, Eltahtawy O, Zeinelabdeen Y, Youness R Life (Basel). 2022; 12(10).

PMID: 36295089 PMC: 9604733. DOI: 10.3390/life12101654.


Vitamin E and Non-Communicable Diseases: A Review.

Ciarcia G, Bianchi S, Tomasello B, Acquaviva R, Malfa G, Naletova I Biomedicines. 2022; 10(10).

PMID: 36289735 PMC: 9599164. DOI: 10.3390/biomedicines10102473.


References
1.
Jackson D, White I, Riley R . Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 2012; 31(29):3805-20. PMC: 3546377. DOI: 10.1002/sim.5453. View

2.
Peh H, Tan W, Liao W, Wong W . Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol. Pharmacol Ther. 2015; 162:152-69. DOI: 10.1016/j.pharmthera.2015.12.003. View

3.
Constantinou C, Papas A, Constantinou A . Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer. 2008; 123(4):739-52. DOI: 10.1002/ijc.23689. View

4.
Bhagat S, Ghone R, Suryakar A, Hundekar P . Lipid peroxidation and antioxidant vitamin status in colorectal cancer patients. Indian J Physiol Pharmacol. 2012; 55(1):72-6. View

5.
Mousavinezhad M, Majdzadeh R, Akbari Sari A, Delavari A, Mohtasham F . The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test. Med J Islam Repub Iran. 2016; 30:366. PMC: 4972062. View